Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × ramosetron × Clear all

NCT01788605 2014-12-08

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

Phase 2 Unknown

Other hematologic neoplasm

Vomiting, Hematologic Neoplasms